Skip to NavigationSkip to content

Pharmafile - Research and Development News

Regeneron has reported a strong showing for its investigational angiopoietin-like 3 (ANGPTL3) antibody evinacumab in the treatment of the rare...
Eli Lilly has unveiled new Phase 4 data supporting the efficacy and safety of Taltz when compared to Janssen’s Tremfya, showing that the former met...
The US FDA has approved BPaL, the TB Alliance’s treatment for drug-resistant tuberculosis (TB).
New Phase 3 data has emerged on AstraZeneca and MSD’s Lynparza (olaparib), showing that the PARP inhibitor achieved its primary endpoint in the...
Janssen’s has secured a label expansion from the European Commission for its Bruton's tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib),...
South African firm Aspen Pharmacare has agreed to pay £8 million to Britain’s NHS over a dispute about overpayment.
Air pollution in cities dramatically increases the risk for and risk of progression of emphysema, a form of chronic obstructive pulmonary disease (...
Chuck Grassley, Chairman of the Senate Finance Committee, has demanded that Novartis give up details on the faulty data scandal surrounding...
A new partnership between MSD and Harvard University hopes to combine the expertise of both parties to carve a path forward in the identification...
Health professionals in the Democratic Republic of Congo (DRC) are now offering two experimental drugs to people infected with Ebola, after they...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches